[The influence of insulin on hyperlactacidemia in the course of alloxan diabetes and experimental dysthyroidism].
Colev
V
V
Sneer
A
A
Dughir
E
E
Papp
E
E
D000140:Acidosis, Lactic / Q000097:blood / Q000188:drug therapy* / Q000209:etiology; D000496:Alloxan; D000818:Animals; D003921:Diabetes Mellitus, Experimental / Q000097:blood / Q000150:complications / Q000188:drug therapy*; D006980:Hyperthyroidism / Q000097:blood / Q000150:complications / Q000188:drug therapy*; D007004:Hypoglycemic Agents / Q000494:pharmacology* / Q000627:therapeutic use; D007037:Hypothyroidism / Q000097:blood / Q000150:complications / Q000188:drug therapy*; D007328:Insulin / Q000494:pharmacology* / Q000627:therapeutic use; D008297:Male; D023421:Models, Animal; D051381:Rats; D017208:Rats, Wistar
D007004:Hypoglycemic Agents; D007328:Insulin; D000496:Alloxan